radioimmunodetection
lorvotuzumab
pexelizumab
immunoscintigraphy
tositumomab
microangiogram
detumomab
cardiography
inolimomab
bispecific
nouse
vectorcardiographically
pritumumab
brentuximab
isoantibody
antiglucagon
lymphangiogram
alloantibody
autoagglutinin
antigenically
patritumab
nanoimmunoassay
neoantigen
conatumumab
sotrovimab
microlymphocytotoxicity
antiplasma
peptibody
third ventricle
dorlixizumab
teplizumab
isohemagglutinin
aeroantigen
cholangiogram
functional magnetic resonance imaging
cardiomyocytolysis
pegol
immunomolecule
monoclonal
immunotube
immunocharacterize
inotuzumab
cardioechography
antiantibody
plasma protein
idiospecific
angiodynography
electromyograph
cine
duligotuzumab